Change in the Clinical Picture of Hospitalized Patients with COVID-19 between the Early and Late Period of Dominance of the Omicron SARS-CoV-2 Variant

被引:11
|
作者
Flisiak, Robert [1 ]
Zarebska-Michaluk, Dorota [2 ]
Dobrowolska, Krystyna [3 ]
Rorat, Marta [4 ,5 ]
Rogalska, Magdalena [1 ]
Krynska, Justyna Anna [1 ]
Moniuszko-Malinowska, Anna [6 ]
Czupryna, Piotr [6 ]
Kozielewicz, Dorota [7 ]
Jaroszewicz, Jerzy [8 ]
Sikorska, Katarzyna [9 ]
Bednarska, Agnieszka [10 ]
Piekarska, Anna [11 ]
Rzymski, Piotr [12 ]
机构
[1] Med Univ Bialystok, Dept Infect Dis & Hepatol, PL-15540 Bialystok, Poland
[2] Jan Kochanowski Univ, Dept Infect Dis & Allergol, PL-25317 Kielce, Poland
[3] Jan Kochanowski Univ, Coll Medicum, PL-25317 Kielce, Poland
[4] Wroclaw Med Univ, Dept Infect Dis & Hepatol, PL-51149 Wroclaw, Poland
[5] Wroclaw Med Univ, Dept Forens Med, PL-50367 Wroclaw, Poland
[6] Med Univ Bialystok, Dept Infect Dis & Neuroinfect, PL-15809 Bialystok, Poland
[7] Nicolaus Copernicus Univ, Fac Med, Dept Infect Dis & Hepatol, Coll Medicum Bydgoszcz, PL-87100 Torun, Poland
[8] Med Univ Silesia, Dept Infect Dis & Hepatol, PL-41902 Bytom, Poland
[9] Med Univ Gdansk, Fac Hlth Sci, Div Trop & Parasit Dis, PL-80210 Gdansk, Poland
[10] Med Univ Warsaw, Dept Adults Infect Dis, Hosp Infect Dis, PL-02091 Warsaw, Poland
[11] Med Univ Lodz, Dept Infect Dis & Hepatol, PL-90419 Lodz, Poland
[12] Poznan Univ Med Sci, Dept Environm Med, PL-60806 Poznan, Poland
关键词
SARS-CoV-2; COVID-19; Omicron; mortality; severity; INFECTION RECOMMENDATIONS; POLISH ASSOCIATION; EPIDEMIOLOGISTS; MANAGEMENT; OUTCOMES; WAVES;
D O I
10.3390/jcm12175572
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study aimed to compare the clinical picture of COVID-19 in the initial and later period of Omicron dominance and to identify populations still at risk. A retrospective comparison of the clinical data of 965 patients hospitalized during the early period of Omicron's dominance (EO, January-June 2022) with 897 patients from a later period (LO, July 2022-April 2023) from the SARSTer database was performed. Patients hospitalized during LO, compared to EO, were older, had a better clinical condition on admission, had a lower need for oxygen and mechanical ventilation, had less frequent lung involvement in imaging, and showed much faster clinical improvement. Moreover, the overall mortality during EO was 14%, higher than that in LO-9%. Despite the milder course of the disease, mortality exceeding 15% was similar in both groups among patients with lung involvement. The accumulation of risk factors such as an age of 60+, comorbidities, lung involvement, and oxygen saturation <90% resulted in a constant need for oxygen in 98% of patients, an 8% risk of mechanical ventilation, and a 30% mortality rate in the LO period. Multiple logistic regression revealed lower odds of death during the LO phase. Despite the milder course of infections caused by the currently dominant subvariants, COVID-19 prophylaxis is necessary in people over 60 years of age, especially those with comorbidities, and in the case of pneumonia and respiratory failure.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] SARS-CoV-2 RNA in exhaled air of hospitalized COVID-19 patients
    Lisa Kurver
    Corné H. van den Kieboom
    Kjerstin Lanke
    Dimitri A. Diavatopoulos
    Gijs J. Overheul
    Mihai G. Netea
    Jaap ten Oever
    Reinout van Crevel
    Karin Mulders-Manders
    Frank L. van de Veerdonk
    Heiman Wertheim
    Jeroen Schouten
    Janette Rahamat-Langendoen
    Ronald P. van Rij
    Teun Bousema
    Arjan van Laarhoven
    Marien I. de Jonge
    Scientific Reports, 12
  • [32] SARS-CoV-2 and hearing: An audiometric analysis of COVID-19 hospitalized patients
    Francisco Alves de Sousa
    Rodrigo Pinto Costa
    Sandra Xará
    Ana Nóbrega Pinto
    Cecília Almeida e Sousa
    Journal of Otology, 2021, 16 (03) : 158 - 164
  • [33] SARS-CoV-2 and hearing: An audiometric analysis of COVID-19 hospitalized patients
    de Sousa, Francisco Alves
    Costa, Rodrigo Pinto
    Xara, Sandra
    Pinto, Ana Nobrega
    Almeida e Sousa, Cecilia
    JOURNAL OF OTOLOGY, 2021, 16 (03) : 158 - 164
  • [34] SARS-CoV-2 RNA in exhaled air of hospitalized COVID-19 patients
    van den Kieboom, C.
    Kurver, L.
    Lanke, K.
    Diavatopoulos, D.
    Overheul, G.
    Netea, M.
    Ten Oever, J.
    Van Crevel, R.
    Mulders-Manders, K.
    Van De Veerdonk, F.
    Wertheim, H.
    Schouten, J.
    Rahamat-Langendoen, J.
    Van Rij, R.
    Bousema, T.
    Van Laarhoven, A.
    De Jonge, M.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [35] Value of Laboratory Indicators in Predicting Pneumonia in Symptomatic COVID-19 Patients Infected with the SARS-CoV-2 Omicron Variant
    Zhu, Kongbo
    Ma, Shaolei
    Chen, Hui
    Xie, Jianfeng
    Huang, Dan
    Fu, Cuiping
    Ma, Genshan
    Huang, Yingzi
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 1159 - 1170
  • [36] COVID-19 vaccination and SARS-CoV-2 Omicron (B.1.1.529) variant: a at the end of the tunnel?
    Mattiuzzi, Camilla
    Henry, Brandon M.
    Lippi, Giuseppe
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 118 : 167 - 168
  • [37] The impact of the COVID-19 vaccination programme on symptomatic and severe SARS-CoV-2 infection during a period of Omicron variant dominance in Ireland, December 2021 to March 2023
    Marron, Louise
    Mateo-Urdiales, Alberto
    O'Donnell, Joan
    Robinson, Eve
    Domegan, Lisa
    EUROSURVEILLANCE, 2024, 29 (28)
  • [38] Clinical characteristics of COVID-19 in hospitalized children during the Omicron variant predominant period
    Shoji, Kensuke
    Akiyama, Takayuki
    Tsuzuki, Shinya
    Matsunaga, Nobuaki
    Asai, Yusuke
    Suzuki, Setsuko
    Iwamoto, Noriko
    Funaki, Takanori
    Ohmagari, Norio
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (11) : 1531 - 1535
  • [39] Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19
    Wu, Can-rong
    Yin, Wan-chao
    Jiang, Yi
    Xu, H. Eric
    ACTA PHARMACOLOGICA SINICA, 2022, 43 (12) : 3021 - 3033
  • [40] COVID-19: Omicron - the latest, the least virulent, but probably not the last variant of concern of SARS-CoV-2
    Bruessow, Harald
    MICROBIAL BIOTECHNOLOGY, 2022, 15 (07): : 1927 - 1939